Skip to content

Author

P. Waghmare

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Casein Kinase 1 and CK2 as Therapeutic Targets in Cancer: Molecular Pharmacology, Toxicological Considerations, and Clinical Progress.

Novel dual-therapy approaches targeting CK1/CK2-regulated pathways have further improved the therapeutic specificity and efficacy and hold great promise for selectively targeting cancer-causing signaling pathways and advancing cancer precision medicine.

P. Waghmare, A. Chabukswar, K. Raut et al. · 0 citations
Review Open access Jul 2026

Smart Drug Design: AI in Transcriptional Modulation and Clinical Innovation

AI-driven approaches in transcription modulator discovery are highlighted, including in silico target identification, multi-omics integration, and structure–activity optimization, and the importance of explainable AI and personalised therapeutics in advancing precision medicine and next-generation transcription-based d...

A. Pimpale, P. Waghmare, Pallavi Zode et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.